665 related articles for article (PubMed ID: 14644723)
41. Optical coherence tomographic patterns in diabetic macular oedema: prediction of visual outcome after focal laser photocoagulation.
Kim NR; Kim YJ; Chin HS; Moon YS
Br J Ophthalmol; 2009 Jul; 93(7):901-5. PubMed ID: 19254904
[TBL] [Abstract][Full Text] [Related]
42. Quantification of macular and optic disc hyperfluorescence after phacoemulsification in diabetes mellitus.
Escaravage GK; Cohen KL; Patel SB; Hartnett ME; Armstrong BD; Janowski CM
J Cataract Refract Surg; 2006 May; 32(5):803-11. PubMed ID: 16765799
[TBL] [Abstract][Full Text] [Related]
43. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
[TBL] [Abstract][Full Text] [Related]
44. Red krypton and blue-green argon panretinal laser photocoagulation for proliferative diabetic retinopathy: a laboratory and clinical comparison.
Blankenship GW
Trans Am Ophthalmol Soc; 1986; 84():967-1003. PubMed ID: 2438841
[TBL] [Abstract][Full Text] [Related]
45. [Treatment of diabetic cystoid macular edema by argon laser photocoagulation].
Gaudric A; Ramioul E; Chaine G; Coscas G
J Fr Ophtalmol; 1984; 7(4):291-304. PubMed ID: 6541668
[TBL] [Abstract][Full Text] [Related]
46. Optical coherence tomography fast versus regular macular thickness mapping in diabetic retinopathy.
Ceklic L; Maár N; Neubauer AS
Ophthalmic Res; 2008; 40(5):235-40. PubMed ID: 18437033
[TBL] [Abstract][Full Text] [Related]
47. Optical coherence tomography findings in persistent diabetic macular edema: the vitreomacular interface.
Ghazi NG; Ciralsky JB; Shah SM; Campochiaro PA; Haller JA
Am J Ophthalmol; 2007 Nov; 144(5):747-754. PubMed ID: 17869207
[TBL] [Abstract][Full Text] [Related]
48. Characterization of macular edema from various etiologies by optical coherence tomography.
Catier A; Tadayoni R; Paques M; Erginay A; Haouchine B; Gaudric A; Massin P
Am J Ophthalmol; 2005 Aug; 140(2):200-6. PubMed ID: 15992752
[TBL] [Abstract][Full Text] [Related]
49. Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy.
Luttrull JK; Musch DC; Spink CA
Eye (Lond); 2008 May; 22(5):607-12. PubMed ID: 17293791
[TBL] [Abstract][Full Text] [Related]
50. Randomised controlled trial of posterior sub-Tenon triamcinolone as adjunct to panretinal photocoagulation for treatment of diabetic retinopathy.
Unoki N; Nishijima K; Kita M; Suzuma K; Watanabe D; Oh H; Kimura T; Sakamoto A; Yoshimura N
Br J Ophthalmol; 2009 Jun; 93(6):765-70. PubMed ID: 19218250
[TBL] [Abstract][Full Text] [Related]
51. The rationale of argon green laser photocoagulation for diabetic maculopathy.
Dastur YK
J Postgrad Med; 1994; 40(1):13-7. PubMed ID: 8568707
[TBL] [Abstract][Full Text] [Related]
52. Changes in the Macular Ganglion Cell Complex Thickness and Central Macular Thickness after Argon Laser Panretinal Photocoagulation.
Demirok G; Kocamaz MF; Topalak Y; Altay Y; Tabakci B; Şengün A
Semin Ophthalmol; 2017; 32(6):759-763. PubMed ID: 27715375
[TBL] [Abstract][Full Text] [Related]
53. The natural history of macular edema after cataract surgery in diabetes.
Dowler JG; Sehmi KS; Hykin PG; Hamilton AM
Ophthalmology; 1999 Apr; 106(4):663-8. PubMed ID: 10201584
[TBL] [Abstract][Full Text] [Related]
54. [The study on changes of macular light sensitivity before and after photocoagulation for diabetic macular edema].
Lai Y; Gao R; Wu D
Zhonghua Yan Ke Za Zhi; 1996 Sep; 32(5):362-5. PubMed ID: 9590829
[TBL] [Abstract][Full Text] [Related]
55. Contrast sensitivity in diabetic retinopathy after panretinal photocoagulation.
Khosla PK; Rao V; Tewari HK; Kumar A
Ophthalmic Surg; 1994 Aug; 25(8):516-20. PubMed ID: 7970533
[TBL] [Abstract][Full Text] [Related]
56. Retinal vessel analyzer measurements of the effect of panretinal photocoagulation on the retinal arteriolar diameter in diabetic retinopathy.
Mendrinos E; Mangioris G; Papadopoulou DN; Dosso AA; Pournaras CJ
Retina; 2010 Apr; 30(4):555-61. PubMed ID: 20010452
[TBL] [Abstract][Full Text] [Related]
57. Changes in choroidal thickness after panretinal photocoagulation in patients with type 2 diabetes.
Zhu Y; Zhang T; Wang K; Xu G; Huang X
Retina; 2015 Apr; 35(4):695-703. PubMed ID: 25462436
[TBL] [Abstract][Full Text] [Related]
58. Prognostic value of multifocal electroretinography and optical coherence tomography in eyes undergoing panretinal photocoagulation for diabetic retinopathy.
Zhu Y; Zhang T; Wang KY; Xu GZ
Invest Ophthalmol Vis Sci; 2014 Aug; 55(10):6358-64. PubMed ID: 25146984
[TBL] [Abstract][Full Text] [Related]
59. One-year follow-up of macular ganglion cell layer and peripapillary retinal nerve fibre layer thickness changes after panretinal photocoagulation.
Kim JJ; Im JC; Shin JP; Kim IT; Park DH
Br J Ophthalmol; 2014 Feb; 98(2):213-7. PubMed ID: 24258287
[TBL] [Abstract][Full Text] [Related]
60. Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy.
Bandello F; Polito A; Pognuz DR; Monaco P; Dimastrogiovanni A; Paissios J
Arch Ophthalmol; 2006 May; 124(5):643-50. PubMed ID: 16682585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
